AIDS therapy / Raphael Dolin, Henry Masur, Michael S. Saag.
Publication details: New York : Churchill Livingstone, c2003.Edition: 2nd editionDescription: xx, 1024 p. : ill. ; 29 cmISBN:- 0443065942
- WC 503.2 A2885
- WC 503.2
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Book Open Access
|
Health Sciences Library | WC 503.2 A2885 2003 (Browse shelf(Opens below)) | 1 | Available | MBAL22010720 | |
|
Book Open Access
|
Health Sciences Library | WC 503.2 A2885 2003 (Browse shelf(Opens below)) | 2 | Available | MBAL22010724 |
Includes bibliographical references and index.
Contents
Section I : Diagnosis of HIV infection
chapter 1: Establishing the diagnosis of HIV Infection
Section II : Antiretroviral therapy
chapter 2: Zidovudine
chapter 3: Didanosine
chapter 4: Zalcitabine
chapter 5: Stavudine
chapter 6: Lamivudine
chapter 7: Emitricitabine
chapter 8: Abacavir
chapter 9: Delavirdine
chapter 10: Nevirapine
chapter 11: Efavirenz
chapter 12: Saquinavir
chapter 13: Ritonavir
chapter 14: Indivavir
chapter 15: Nelfinavir
chapter 16: Amprenavir
chapter 17: Lopinavir
chapter 18: Tenofovir Disoproxil fumarate
chapter 19: Inhibitors of HIV attachmenet and fusion
chapter 20: New drugs in development
Section III: Immune-Based therapies
chapter 21: General immune-based therapies in the management of HIV-infected patients
chapter 22: Approach to HIV antigen -specific immune enhancement
Section IV: Other therapies including alternative therapies
chapter 23: Complemetary and alternatie therapies
Section V: Strategies for managing antiretroviral therapies
chapter 24: Acute HIV infection
chapter 25: Occupational and nonoccupational exposure management
chapter 26: HIV resistance testing in clinical practice
chapter 27: Strategic use of Antiretroviral therapy
chapter 28: Managing pregnant patients
Section VI: Diagnosis, therapy, and prevention of opportunistic processes
chapter 29: Pneumocystosis
chapter 30: Toxoplasmosis
chapter 31: Cryptosporidium, isopora and cyclospora infections
chapter 32: Microsporidiosis
chapter 33: Mycobacterium tuberclosis infection
chapter 34: Mycobaterium avium complex and other atypical mycobterial infections
chapter 35: Bartonellosis
chapter 36: Cryptococcosis
chapter 37: Histoplasmosis
chapter 38: Coccidiodomycosis
chapter 39: Candidiasis
chapter 40: Mycoses caused by moulds
chapter 41: Herpes simplex virus infections
chapter 42: Varilla-zoster virus infections
chapter 43: Cytomegalovirus diseases
chapter 44: Human herpesvirus -6 and Herpesvirus infections
chapter 45: Epsten-Barr Virus and Kaposi's Sarcoma-associated herpesvirus
chapter 46: Hepatitis viruses
chapter 47: Sexually transmitted human papillomavirus infection
chapter 48: JC Virus neurologic infection
chapter 49: Sexually transmitted diseases
chapter 50: Kaposi's sarcoma
chapter 51: Non Hodgkin's Lymphoma
chapter 52: Primary care: Daily management of HIV infected patients
Section VII: Approach to specific syndromes
chapter 53: Wasting syndrome
chapter 54: Neurologic disease
chapter 55: Oropharyngeal disease
chapter 56: Oropharyngeal disease
chapter 57: Ophthalmologic disease
chapter 58: Hematologic disease
chapter 59: Cardiac disease
chapter 60: Respiratory disease
chapter 61: Renal disease
chapter 62: Diabetes, insulin resistance, lip disorders, and fat redistribution syndromes
chapter 63: Adrenal, gonadal and thyroid disorders
chapter 64: Diseases of the esophagus , stomach and Bowel
chapter 65: Hepatic and hepatobiliary diseases
Section VIII: Drug administration and interactions
Chapter 66: Drug administration and interactions
Chapter 67: AIDS-Related medications
There are no comments on this title.